.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Fuji
Chinese Patent Office
Teva
Express Scripts
Fish and Richardson
Dow
QuintilesIMS
Julphar
UBS

Generated: December 17, 2017

DrugPatentWatch Database Preview

METHAMPHETAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Methamphetamine Hydrochloride, and when can generic versions of Methamphetamine Hydrochloride launch?

Methamphetamine Hydrochloride is a drug marketed by Able, Mayne Pharma Inc, Rexar, Teva, and West-ward Pharms Int. and is included in five NDAs.

The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AbleMETHAMPHETAMINE HYDROCHLORIDEmethamphetamine hydrochlorideTABLET;ORAL040529-001Feb 25, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
RexarMETHAMPHETAMINE HYDROCHLORIDEmethamphetamine hydrochlorideTABLET;ORAL084931-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma IncMETHAMPHETAMINE HYDROCHLORIDEmethamphetamine hydrochlorideTABLET;ORAL091189-001Apr 21, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
RexarMETHAMPHETAMINE HYDROCHLORIDEmethamphetamine hydrochlorideTABLET;ORAL084931-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntMETHAMPHETAMINE HYDROCHLORIDEmethamphetamine hydrochlorideTABLET;ORAL203846-001Nov 17, 2015AARXNoNo► Subscribe► Subscribe► Subscribe
TevaMETHAMPHETAMINE HYDROCHLORIDEmethamphetamine hydrochlorideTABLET;ORAL086359-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Julphar
US Army
Fish and Richardson
Dow
Argus Health
Citi
AstraZeneca
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot